Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2019 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update

RUTHERFORD, N.J., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic,...
July 15, 2019 16:22 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Strategic Transactions

Sale of BioPharma business to Interpace Diagnostics Group, Inc. Clinical services business acquired by siParadigm Diagnostic Informatics Significantly reduces its debt burden and will continue to...
May 20, 2019 17:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update

RUTHERFORD, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics,...
April 16, 2019 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics,...
January 31, 2019 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
January 28, 2019 22:33 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
January 28, 2019 16:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
January 16, 2019 08:45 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Issues Letter to Shareholders

RUTHERFORD, N.J., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
January 14, 2019 17:29 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
January 09, 2019 23:20 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...